Reconsidering the role for digoxin in the management of acute heart failure syndromes

JAMA

Volumn 302, Issue 19, 2009, Pages 2146-2147

  Gheorghiade, Mihai ^a   Braunwald, Eugene ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; DRUG EFFICACY; DRUG SAFETY; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MORTALITY; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; CARDIOLOGY; CARDIOTONIC AGENTS; DIGOXIN; DRUG UTILIZATION; HEART FAILURE; HUMANS;

EID: 71749086540     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1657     Document Type: Note

References (10)

1. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336(8):525-533.
2. Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006;113(21):2556-2564. (Pubitemid 43948035)
3. Gheorghiade M, Zannad F, Sopko G, et al; International Working Group on Acute Heart Failure Syndromes. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112(25):3958-3968.
4. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347(18):1403- 1411. (Pubitemid 35239712)
5. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53(7):557-573.
6. Gheorghiade M, Adams KF, Cleland JG, et al; Acute Heart Failure Syndromes International Working Group. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009;157(6):957-970.
7. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005;293(15):1900-1905. (Pubitemid 40548187)
8. O'Connor MC. PROTECT. Study presented at: the late breaking clinical trial of the 13th Annual Scientific Meeting of the Heart Failure Society of America; September 13-16, 2009; Boston, MA.
9. Ahmed A, Rich MW, Love TE, et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J. 2006;27(2):178-186. (Pubitemid 43069034)
10. Adams KF Jr, Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group Trial: a retrospective analysis. J Am Coll Cardiol. 2005;46(3):497-504.